## **Core Concept**
Multibacillary leprosy is a more severe form of leprosy characterized by a higher bacterial load and more widespread disease. It requires more intensive treatment compared to paucibacillary leprosy. The World Health Organization (WHO) recommends multidrug therapy (MDT) for the treatment of leprosy.

## **Why the Correct Answer is Right**
The correct duration for the treatment of multibacillary leprosy is 12 months, according to the WHO MDT regimen. This regimen consists of rifampicin, clofazimine, and dapsone. The prolonged treatment duration is necessary to ensure the eradication of the bacteria, given the higher bacterial load in multibacillary leprosy.

## **Why Each Wrong Option is Incorrect**
* **Option A:** A treatment duration of 6 months is actually recommended for paucibacillary leprosy, not multibacillary leprosy.
* **Option B:** While some regimens might have variations, 9 months is not the standard recommended duration for multibacillary leprosy.
* **Option D:** A treatment duration of 18 months or longer might be considered in certain cases of relapse or resistance, but 12 months is the standard for initial treatment of multibacillary leprosy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the WHO MDT regimen for multibacillary leprosy includes rifampicin 600 mg once monthly, clofazimine 300 mg once monthly and 50 mg daily, and dapsone 100 mg daily, all for 12 months. Early diagnosis and treatment are crucial to prevent disabilities associated with leprosy.

## **Correct Answer:** . 12 months.